Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-Pseudomonas cumA2 Polyclonal Antibody

Catalog #:   PXX20401 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: WP_046510211.1
Overview

Catalog No.

PXX20401

Species reactivity

Pseudomonas

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Pseudomonas cumA2 (Met1-Phe186).

Tested applications

ELISA: 1:4000-1:8000, WB: 1:1000-1:4000

Target

MULTISPECIES: 3-phenylpropionate/cinnamic acid dioxygenase subunit beta, MULTISPECIES: 3-phenylpropionate/cinnamic acid dioxygenase subunit beta

Purification

Purified by antigen affinity column.

Accession

WP_046510211.1

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • Western Blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with cumA2 antibody (PXX20401) at 1 µg/ml.

    Lane 1: Recombinant Protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 24 kDa
    Observed MW: 24 kDa
References

Immune system dynamics in response to Pseudomonas aeruginosa biofilms., PMID:40506442

Intracellular trafficking of furin enhances cellular intoxication by recombinant immunotoxins based on Pseudomonas exotoxin A., PMID:40485510

Peptide vaccines: an innovative therapeutic approach against antibiotic-resistant bacterial infections., PMID:40469313

Epidermal growth factor receptor specific immunotherapy for SHH medulloblastoma tested in an in vitro blood-brain barrier-model., PMID:40456204

Multi-omics analysis reveals Angelica sinensis-Carthamus tinctorius herb pair ameliorates diabetic retinopathy comorbid with depressive symptoms via the gut-eye-brain axis., PMID:40449450

MPO-ANCA-Associated Hypertrophic Pachymeningitis Mimicking IgG4-Related Disease: A Case Report and Literature Review., PMID:40438183

PcrV in an intranasal adjuvanted tobacco mosaic virus conjugate vaccine mediates protection from Pseudomonas aeruginosa via an early Th1/Th17 skewed localized and systemic immune response., PMID:40424705

Synergistic inhibition of CitH3 and S100A8/A9: A novel therapeutic strategy for mitigating sepsis-induced inflammation and lung injury., PMID:40390290

Immune efficacy of oprH chitosan nanoparticle DNA vaccine against Pseudomonas aeruginosa., PMID:40386097

Highly pure mRNA vaccine provides robust immunization against P. aeruginosa by minimizing type I interferon responses., PMID:40383159

Heterologous Surface Display Reveals Conserved Complement Inhibition and Functional Diversification of Borrelia burgdorferi Elp Proteins., PMID:40376887

In vitro anti-tumor activities of a novel recombinant immunotoxin targeting differentially overexpressed Leucine-rich repeat-containing G-protein-coupled receptor 5 in cervical cancer., PMID:40376858

Mercaptophenylboronic Acid-Mediated Nanozyme Immunochromatographic Assay for Simultaneous Detection of Respiratory Bacteria and Virus., PMID:40344387

Synthesis of the Pentasaccharide Unit of the Pseudomonas aeruginosa Exopolysaccharide Psl Conjugation with CRM197, and Evaluation of Antigenicity in a QS-21/Pam3CSK4-Liposomal Formulation., PMID:40333663

Arginine deiminase-polymeric hybrid nanoconjugates: A potential biodrug for targeted treatment of arginine auxotrophic cancers., PMID:40316084

Recent Advances in Immunotherapeutic and Vaccine-Based Approaches for the Treatment of Drug-Resistant Bacterial Infections., PMID:40315159

Vaccination of a CdrA fragment conferred protection against Pseudomonas aeruginosa in wound infection via inhibition of biofilm formation., PMID:40311213

Canakinumab for the management of pyoderma gangrenosum: a case series of two patients and literature review., PMID:40302177

Antibody-guided identification of Achromobacter xylosoxidans protein antigens in cystic fibrosis., PMID:40298413

TRPV1 Defends the Healthy Murine Cornea against Staphylococcus aureus Adhesion Independently of Sensory Nerve Firing., PMID:40291673

Monoclonal antibodies derived from B cells in subjects with cystic fibrosis reduce Pseudomonas aeruginosa burden in mice., PMID:40272253

The novel antigen, lipopolysaccharide export protein LptH, protects mice against Pseudomonas aeruginosa acute pneumonia in monovalent and multivalent vaccines., PMID:40262371

A new treatment for canine B-cell lymphoma based on a recombinant single-domain antibody immunotoxin derived from Pseudomonas aeruginosa exotoxin A., PMID:40256602

Modular assembly and evaluation of a TROP2-targeting immunotoxin for cancer therapy., PMID:40253026

Flexible PDMS-SERS platform for culture-free diagnosis of bacterial infections in clinical wound care., PMID:40203598

An Antimicrobial and Antifibrotic Coating for Implantable Biosensors., PMID:40136968

GRP78 Nanobody-Directed Immunotoxin Activates Innate Immunity Through STING Pathway to Synergize Tumor Immunotherapy., PMID:40135833

Monosaccharide-Based Synthetic TLR4 Agonist Enhances Vaccine Efficacy against Pseudomonas aeruginosa Challenge., PMID:40129118

Citrullination of NF-κB p65 by PAD2 as a Novel Therapeutic Target for Modulating Macrophage Polarization in Acute Lung Injury., PMID:40087815

Lectin-Based Substrate Detection in Fabry Disease Using the Gb3-Binding Lectins StxB and LecA., PMID:40076891

Pseudomonas aeruginosa Vaccine Development: Lessons, Challenges, and Future Innovations., PMID:40076637

Multimeric, multivalent fusion carrier proteins for site-selective glycoconjugate vaccines simultaneously targeting Staphylococcus aureus and Pseudomonas aeruginosa., PMID:40041805

An engineered peptide derived from the innate immune effector high-mobility group box 1 disrupts and prevents dual-genera biofilms formed by common respiratory tract pathogens., PMID:40036662

Host-Microbe Interactions in Healthy and CSOM-Affected Middle Ears., PMID:40005706

PAPreC: A Pipeline for Antigenicity Prediction Comparison Methods across Bacteria., PMID:39989760

Avian Antibodies as Potential Therapeutic Tools., PMID:39982233

Antibody responses in Klebsiella pneumoniae bloodstream infection: a prospective cohort study., PMID:39952262

Elexacaftor/tezacaftor/ivacaftor and inflammation in children and adolescents with cystic fibrosis: a retrospective dual-center cohort study., PMID:39930791

No tolerance for Pseudomonas in lung transplants., PMID:39908351

Pseudomonas aeruginosa infection induces intragraft lymphocytotoxicity that triggers lung transplant antibody-mediated rejection., PMID:39908350

Pseudomonas aeruginosa sepsis with sacroiliitis in X-linked agammaglobulinaemia., PMID:39900389

Tumor-specific cytosol-penetrating antibodies for antigen- and TME-dependent intracellular cargo delivery., PMID:39895690

Clinical predictors for restrictive allograft syndrome: A nested case-control study., PMID:39892791

State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens., PMID:39870103

Siderophore-based targeted antibody recruitment for promoting immune responses towards Gram-negative pathogens., PMID:39830684

Complex management of GS (Good's syndrome) with persistent COVID-19 infection and polymicrobial infections: A case report., PMID:39811332

Electropositive Magnetic Fluorescent Nanoprobe-Mediated Immunochromatographic Assay for the Ultrasensitive and Simultaneous Detection of Bacteria., PMID:39804983

A signaling molecule from intratumor bacteria promotes trastuzumab resistance in breast cancer cells., PMID:39786928

Atelocollagen-based hydrogel loaded withCotinus coggygriaextract for treatment of type 2 diabetic wounds., PMID:39778335

Lung-kidney axis in cystic fibrosis: Early urinary markers of kidney injury correlate with neutrophil activation and worse lung function., PMID:39753455

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Pseudomonas cumA2 Polyclonal Antibody [PXX20401]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only